Given the pivotal role of the APLN/APLNR axis in vascular maturation positions it as a promising therapeutic target for anti-tumor vascular therapy.This study aims to discover novel APLNR antagonists, investigate their effects on tumor vascular normalization, and evaluate their combinatorial efficacy with existing anticancer therapies. This evidence concerns the gene APLN and neoplasm.